Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment. Clin Cancer Res. 2009 Oct 01; 15(19):6250-7.